Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E20.69 EPS (ttm)2.57 Insider Own0.10% Shs Outstand1.59B Perf Week-3.15%
Market Cap84.67B Forward P/E13.79 EPS next Y3.86 Insider Trans35.60% Shs Float1.57B Perf Month-2.58%
Income4.14B PEG2.19 EPS next Q0.76 Inst Own79.40% Short Float0.97% Perf Quarter9.04%
Sales19.02B P/S4.45 EPS this Y-23.10% Inst Trans14.01% Short Ratio1.91 Perf Half Y13.12%
Book/sh2.94 P/B18.09 EPS next Y22.80% ROA14.50% Target Price65.50 Perf Year24.28%
Cash/sh5.72 P/C9.30 EPS next 5Y9.47% ROE101.40% 52W Range40.86 - 57.83 Perf YTD3.18%
Dividend1.68 P/FCF32.51 EPS past 5Y0.00% ROI23.20% 52W High-8.04% Beta-
Dividend %3.16% Quick Ratio2.60 Sales past 5Y- Gross Margin76.30% 52W Low30.15% ATR1.25
Employees25000 Current Ratio2.80 Sales Q/Q5.40% Oper. Margin31.70% RSI (14)41.85 Volatility1.48% 2.22%
OptionableYes Debt/Eq3.07 EPS Q/Q1.70% Profit Margin21.80% Rel Volume1.46 Prev Close54.08
ShortableYes LT Debt/Eq3.06 EarningsJul 25 BMO Payout61.50% Avg Volume8.05M Price53.18
Recom1.90 SMA20-3.70% SMA50-1.95% SMA2005.45% Volume11,680,900 Change-1.66%
24-Jun-14Reiterated Argus Buy $59 → $65
06-Jan-14Reiterated UBS Neutral $46 → $56
29-Oct-13Reiterated Argus Buy $52 → $59
12-Aug-13Initiated Argus Buy $52
15-May-13Reiterated R. F. Lafferty Buy $47.90 → $61
29-Apr-13Reiterated Barclays Equal Weight $41 → $44
15-Apr-13Reiterated Barclays Equal Weight $37 → $41
28-Jul-14 12:01AM  Obama could curb corporate 'inversions' on his own -ex-U.S. official Reuters
12:01AM  Lew Can Use Tax Rule to Slow Inversions, Ex-Official Says at Bloomberg
27-Jul-14 02:21AM  Obama Calls Offshore Deals 'Unpatriotic' Yet Funds, Investors, Boards Jump Aboard at Forbes
26-Jul-14 01:42PM  Walgreens eyes loophole end run around taxes at USA TODAY
03:05AM  Market Ignores AbbVie's Impressive Sales Due To Reliance On Humira at Seeking Alpha
25-Jul-14 03:39PM  [$$] Humira Sales Lift AbbVie Profit at The Wall Street Journal
02:46PM  Humira Still Key to AbbVie at Motley Fool
02:03PM  AbbVie profit beats estimates on surging Humira sales Reuters
01:35PM  [$$] Humira Sales Lift AbbVie Profit at The Wall Street Journal
12:52PM  [video] Obama Calls Congress to Take Action to Stop Inversions at TheStreet
11:46AM  AbbVie Beats Earnings Views, Sees Slower Humira Gain at Investor's Business Daily
10:52AM  AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus Zacks
10:28AM  AbbVie profit beats estimates on surging Humira sales Reuters
10:12AM  How Will AbbVie (ABBV) Stock React To Its Second Quarter Earnings Beat? at TheStreet
09:54AM  Today's Top Health Care Headlines: AbbVie and GlaxoSmithKline at Motley Fool
09:42AM  AbbVie 2Q profit climbs 2.8 percent AP
09:07AM  MARK CUBAN: If Your Company Is Moving For Tax Reasons, I'm Selling Your Stock Business Insider
09:00AM  AbbVie Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:54AM  Zacks Industry Outlook Highlights: Pfizer, AstraZeneca, AbbVie, Shire and Mylan Zacks
08:49AM  AbbVie Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:44AM  [$$] Humira Sales Lift AbbVie Profit at The Wall Street Journal
08:43AM  AbbVie 2Q profit climbs 2.8 percent AP
08:40AM  AbbVie Earnings Take Back Seat to Shire Merger at 24/7 Wall St.
08:31AM  AbbVie profit beats estimates on surging Humira sales Reuters
08:23AM  Obama Goes On The Attack Against Companies Doing Inversions To Move To Countries Where They Pay Less In Taxes Business Insider
08:19AM  [$$] AbbVie's Plans Hinge on Humira at The Wall Street Journal
08:00AM  AbbVie Profit Tops Analyst Estimates on Humira Sales at Bloomberg
07:59AM  AbbVie beats estimates on surging Humira sales in 2nd quarter Reuters
07:57AM  ABBVIE INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:50AM  AbbVie reports Q2 Global HUMIRA sales up 26.2% to $3.29B theflyonthewall.com
07:47AM  AbbVie Reports Second-Quarter 2014 Financial Results PR Newswire
07:31AM  EMA recommends expanded indication for Humira theflyonthewall.com
07:07AM  Q2 2014 AbbVie Inc Earnings Release - Before Market Open CCBN
06:59AM  [$$] AbbVie's Plans Hinge on Humira at The Wall Street Journal
12:03AM  [$$] AbbVie's Plans Hinge on Humira at The Wall Street Journal
12:02AM  Obama rails against corporate maneuver to evade U.S. taxes Reuters
24-Jul-14 11:03PM  [$$] AbbVie's Plans Hinge on Humira at The Wall Street Journal
09:08PM  [$$] AbbVie's Plans Hinge on Humira at The Wall Street Journal
08:31PM  To Woo Shire, AbbVie Trod Cautiously in Takeover Bid at New York Times
05:42PM  Merck Looks Overpriced Compared To This Sector Peer at Seeking Alpha
03:50PM  Pharma, Biotech M&As Heat Up: Tax Inversion in Focus Zacks
02:07PM  [$$] AbbVie's Plans Hinge on Humira at The Wall Street Journal
01:58PM  Will AbbVie (ABBV) Surprise This Earnings Season? Zacks
12:56PM  Perrigo confirms AB therapeutic equivalent rating for testosterone gel 1.0% at theflyonthewall.com
07:52AM  The Zacks Analyst Blog Highlights: AbbVie, Shire, Amgen, InterMune and Biogen Zacks
06:54AM  GlaxoSmithKline Slumps: GSK Falls 5.9% in Session Zacks
06:00AM  Obama presses to close corporate tax loophole 'inversions' Reuters
23-Jul-14 03:43PM  Biogen Idec Beats And Raises: Reassessing Its Prospects at Seeking Alpha
02:44PM  Surprise: The Real Costs Of Inversions Are Paid By Ordinary Shareholders at Seeking Alpha
01:16PM  Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 Zacks
12:44PM  AbbVie to Host Second-Quarter Earnings Conference Call PR Newswire
10:36AM  Durbin Harshly Criticizes Walgreen for Tax Inversion Plans at The Wall Street Journal
09:41AM  [video] Faber Report: Inversion train rolling at CNBC
09:35AM  Healthcare Spending Uptrend: 3 Medical Stocks for Strong Growth Zacks
08:44AM  Shire to spend about $225M on drug collaboration AP
12:01AM  Doctors Dilemma: Who Gets Costly Cure for Deadly Virus at Bloomberg
12:01AM  Doctors Dilemma: Who Gets Costly Cure for Deadly Hepatitis C Virus? Bloomberg
22-Jul-14 05:30PM  Dividend Growth Investing: An Open Portfolio For Your Review at Seeking Alpha
03:30PM  Allergan, a Valeant Takeover Target, Plans 1,500 Job Cuts Zacks
02:38PM  [video] Don't Expect Tax Inversion Fever to Break Anytime Soon at TheStreet
02:04PM  Senate Panel Takes On Tax Inversions at New York Times
11:41AM  Top U.S. lawmaker wants corporate tax loophole 'plugged now' Reuters
10:52AM  No Need To Envy Tax-Inversion Takeovers: Better Tax Deal Awaits at Forbes
10:01AM  Shire's Q2 Earnings Strong but Overshadowed by AbbVie Deal Zacks
09:32AM  Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings at Motley Fool
21-Jul-14 07:05PM  U.S. Senate panel to debate wave of corporate tax-avoidance deals Reuters
03:58PM  Abbvie's $8 billion in tax breaks from Shire deal may come just in time at MarketWatch
02:10PM  Welcome to Ireland, AbbVie at Motley Fool
02:06PM  AbbVie Set to Acquire UK-Based Shire in Q4 Zacks
01:03PM  ABBV, MRK And PFE, Pushing Health Care Sector Downward at TheStreet
11:34AM  Tax inversions allow firms to avoid state taxes at USA TODAY
11:00AM  [video] Mega drug merger at CNBC
10:41AM  Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers at The Wall Street Journal
10:22AM  Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers at The Wall Street Journal
09:33AM  AbbVie Gets Its 'Tax Break' In Shire at Seeking Alpha
08:01AM  AbbVie acquisition positive, says Argus at theflyonthewall.com
04:30AM  Why AbbVie Inc Is Buying Shire PLC at Motley Fool
12:00AM  Sullivan & Cromwell Advises AbbVie on Deal: Business of Law at Bloomberg
20-Jul-14 12:21PM  Takeover deals highlight bets on equities outperforming bonds at Financial Times
01:29AM  S&P 500 And Dividend Aristocrat Dogs Mark 2.5% To 20% July Upsides at Seeking Alpha
19-Jul-14 01:06PM  3 Dividend Value Stocks to Boost Your Income at Motley Fool
08:00AM  Can Anything Stop Drug Companies From Fleeing The U.S. Tax System? at Forbes
07:05AM  The AbbVie, Shire Tax Inversion Will Actually Increase US Tax Revenues at Forbes
12:00AM  AbbVie Is Biggest to Quit U.S. Address in $55 Billion Shire Deal at Bloomberg
18-Jul-14 11:09PM  [$$] AbbVie to Buy Shire for $54 Billion at The Wall Street Journal
11:08PM  [$$] Taxing Terms in AbbVie's Shire Deal at The Wall Street Journal
10:39PM  [$$] AbbVie to Buy Shire for $54 Billion at The Wall Street Journal
10:39PM  [$$] Taxing Terms in AbbVie's Shire Deal at The Wall Street Journal
09:49PM  [$$] Taxing Terms in AbbVie's Shire Deal at The Wall Street Journal
09:49PM  [$$] AbbVie to Buy Shire for $54 Billion at The Wall Street Journal
09:29PM  [$$] Taxing Terms in AbbVie's Shire Deal at The Wall Street Journal
08:47PM  [$$] AbbVie to Buy Shire for $54 Billion at The Wall Street Journal
08:01PM  [video] The $55B Deal That Jack Lew Probably Doesn't Like at Bloomberg
07:12PM  With Shire, Did AbbVie Count Its Chickens Before They Hatched? at Motley Fool
06:34PM  AbbVie Flees U.S. Tax Burden With $54B Shire Deal at Wall St. Cheat Sheet
06:04PM  AbbVie purchase of Shire worth the premium, Barron's reports at theflyonthewall.com
05:19PM  Stocks recover from Thursday's decline and refocus on earnings Hot Stock Minute
05:16PM  [video] Pharma inversion deals at CNBC
05:11PM  AbbVie: Shire Buy More Than Just Taxes Investor's Business Daily
05:08PM  U.S. drugmaker AbbVie finally wins Dublin's Shire with $55 billion deal Reuters
AbbVie Inc., a research-based biopharmaceutical company, is engaged in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; Norvir , a protease inhibitor that is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013, AbbVie Inc. operates independently of Abbott Laboratories.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GONZALEZ RICHARD AChairman of the Board and CEOMar 04Sale51.204,799245,706395,403Mar 04 05:13 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCMar 03Sale50.034,143207,284273,585Mar 04 05:18 PM
SALEKI-GERHARDT AZITASVP, OperationsMar 03Sale50.252,443122,76085,828Mar 04 05:17 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 03Sale50.223,948198,259180,068Mar 04 05:12 PM
ALBAN CARLOSEVP, Commercial OperationsMar 03Sale50.092,882144,356205,138Mar 04 05:10 PM
HURWICH THOMAS A.VP, ControllerFeb 18Option Exercise44.939,138410,57061,016Feb 19 05:33 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCFeb 18Option Exercise43.218,928385,779256,224Feb 19 05:35 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 18Sale51.2346523,82283,913Feb 19 05:35 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 10Option Exercise45.061,46666,05865,856Feb 12 04:49 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 05Sale47.8468732,86664,390Feb 07 05:08 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 05Sale47.781,46069,76385,470Feb 07 05:08 PM